THE LEADER IN
Bloonics was established in 2016 to both end the harmful criminalization of medical cannabis users and advance cannabinoid science. We are developing the first system to detect impairment, looking beyond the mere presence of a molecule and providing meaningful context for our users.
SHAPING SMARTER WORKPLACE POLICIES
Retain Employees without Sacrificing the Safety or Productivity of your Worksite
Employers are struggling to navigate the ever changing regulatory landscape for cannabis. Not only are more employees and job candidates testing positive for cannabis than ever, but courts are also changing the rules around the enforceability of these findings.
We believe that the answer lies in screening specifically for impairment.
With the LuciX system you can safely retain responsible cannabis using employees while avoiding unnecessary turnover.
BRINGING JUSTICE BACK TO THE ROADSIDE
Drugged Driving Enforcement is Broken
The Drug Recognition Expert (DRE) protocol asks officers to perform complicated neuro-opthamological examinations manually, with just two weeks of training.
We think there is a better way.
Learn more about how we plan on removing error and subjectivity from the procedure — avoiding needless arrests, advancing equality in policing, and protecting public safety.
KEY ADVANTAGES OF THE LUCIX PLATFORM
Get actionable readouts in less than 15 minutes, allowing your employees to return to work faster and reducing overtime burden for officers.
Our synthetic biology enabled assay can be produced and sold for a fraction of the competition, while our eye scanner automates costly DRE testing.
FOCUSED ON WHAT MATTERS
We isolate only the active cannabinoids and specific signatures of impairment, avoiding unnecessary actions against responsible users
EASY TO USE
Our tooling is designed to be used with minimal training, making it easier to deploy broadly in your organization or precinct
WHAT WE DO
COMMERCIALIZING IMPAIRMENT DETECTION SYSTEMS
At Bloonics, we believe that our solutions will soon become the gold standard for the drug testing industry. We offer customizable tooling for our clients, designed to adapt to any regulatory framework for drug enforcement today with an eye towards tomorrow.
From the start of our development process we ensured that our tests can be performed nearly anywhere and on anyone for a fraction of the cost and time of the competition.
With our platform technology (the LuciX system), more sensible and equitable policy can formed and implemented with ease.
To advance our understanding of cannabinoids
For years, cannabis has existed under a social stigma hindering research efforts. Presently, no tools exist which can assay the profile of endo-and phyto-cannabinoids in a subject outside of the lab. The lack of reliable data on both cannabinoids and their effects has led to confusion among law enforcement, policymakers and medical practitioners alike. Unfortunately its the patients who have suffered the most as a result. We want to change that.
"There is a need for more basic research on the pharmacology of cannabis to provide biological and behavioural measures of cannabis-impaired driving that can be used to identify and deter drug-impaired driving."
European Monitoring Centre for Drug and Addiction (EMCDDA)
GET IN TOUCH
Whether you're a prospective partner, a research collaborator, or just a curious person, we’re happy to hear from you!
Contact us today to learn more about our business and how you can benefit from working with us.
5641 JA, Eindhoven,